Skip to main content Skip to section navigation Skip to footer
Careers News & Media Contact
OPKO Health, Inc. OPKO Health, Inc.
  • Therapies
    • Overview
    • Ngenla
    • Rayaldee
  • Research
    • Overview
    • Pipeline
    • Publications
    • Scientific Presentations
  • Diagnostics
  • Company
    • Overview
    • Leadership
    • Locations
  • Partnerships
  • Investors
    • Overview
    • News / Events
    • Presentations
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • News & Media
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Presentations
  • Company Info
    • Overview
    • Proxy Materials
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Form 8937
  • Governance
    • Overview
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Feb 08, 2017 8:00am EST

OPKO Spain to Start Trial of Once-A-Year Intra-Articular Injectable for Osteoarthritis

Feb 07, 2017 8:00am EST

OPKO Health Promotes Thomas Nusbickel to Renal Division Chief Commercial Officer

Feb 01, 2017 8:30am EST

OPKO’S GeneDx Announces Research Collaboration with the Wellcome Trust Sanger Institute

Jan 10, 2017 8:30am EST

OPKO Investee Zebra Biologics Announces Collaboration with AbbVie to Discover New Antibody Therapeutics

Jan 09, 2017 1:31pm EST

OPKO Announces Initiation of Claros® 1 Clinical Trial for Total PSA

Jan 04, 2017 8:30am EST

OPKO Health to Present at the J.P. Morgan 35th Annual Healthcare Conference

Dec 30, 2016 8:25am EST

OPKO Health Provides Update on hGH-CTP Clinical Programs

Dec 19, 2016 9:00am EST

OPKO Health to be Added to the NASDAQ Biotechnology Index

Nov 30, 2016 8:00am EST

OPKO Health to Participate at Three Investment Conferences in December

Nov 23, 2016 11:31am EST

OPKO Announces U.S. Launch of RAYALDEE™

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • Page 27
  • Page 28
  • …
  • Page 52
  • Next Pagearrow_forward
rss_feed News RSS
  • emailEmail Alerts
  • location_cityCompany Profile
  • contact_pageContacts
  • rss_feedRSS News Feed
  • account_treeSitemap

OPKO Health, Inc.
4400 Biscayne Boulevard
Miami, FL 33137


T: 305-575-4100
contact@opko.com

©2025 OPKO Health, Inc. All Rights Reserved.
Privacy Policy Governance Terms of use Sitemap